This biotech small-cap's grown its dividend by 140% since 2016! So with an 8.3% yield, is now the time to add it to my Stocks ...
As of Friday, January 23, Coherus Oncology, Inc.’s CHRS share price has surged by 21.70%, which has investors questioning if ...
DHR is set to report Q4 results on Jan. 28, with revenues seen up 3.9% and bioprocessing and diagnostics strength in focus.
Nirsevimab may offer infants stronger protection against severe respiratory syncytial virus than maternal vaccination, ...
Blau Farmacêutica, a Brazilian pharmaceutical company listed on Brazilian Stock Market (B3) and a regional leader in hospital pharmaceuticals with a strong presence across Latin America, announces an ...
Kiniksa (KNSA) shifts from survival to growth as Arcalyst nears blockbuster sales and pipeline KPL-387 readouts loom—get the ...
Berger has participated in meetings (lectures, advisory boards, consultations) sponsored and compensated by pharmaceutical ...
As of Friday, January 23, Jade Biosciences, Inc.’s JBIO share price has dipped by 5.64%, which has investors questioning if ...
To this day, animal testing remains one of the most controversial issues in animal rights. Activists have been fighting ...
Elfenbein, a physician who trained at Johns Hopkins and contracted for the United States Secret Service (USSS), earned ...
The panel discussion, “Innovations in Breast Cancer Treatment,” examined the challenge of maintaining or increasing access to care as breast cancer treatment becomes more stratified through biomarker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results